Stockreport

NeuroRPM to Deploy AI-Enabled Digital Biomarker Monitoring for Annovis Bio's Parkinson's Disease Clinical Trial [Yahoo! Finance]

Annovis Bio, Inc.  (ANVS) 
PDF that its FDA-cleared wearable platform will be used for digital biomarker monitoring in Annovis Bio 's ANVS-25002 open-label Parkinson's disease clinical trial. NeuroRPM [Read more]